Sadanori Furudate Selected Research

Peplomycin

1/2017	Retrospective Investigation of Cutaneous Squamous Cell Carcinoma on the Lip Treated with Peplomycin Administered Through a Superficial Temporal Artery.
1/2015	Immunomodulatory effects of peplomycin on immunosuppressive and cytotoxic cells in the lesional skin of cutaneous squamous cell carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sadanori Furudate Research Topics

Disease

21	Neoplasms (Cancer) 03/2018 - 01/2012
20	Melanoma (Melanoma, Malignant) 09/2021 - 11/2015
5	Mycosis Fungoides 04/2018 - 01/2016
3	Pemphigus (Pemphigus Vulgaris) 12/2017 - 09/2013
3	Carcinoma (Carcinomatosis) 01/2017 - 09/2012
3	Hemangiosarcoma (Angiosarcoma) 01/2013 - 01/2012
2	Psoriasis (Pustulosis Palmaris et Plantaris) 03/2021 - 05/2015
2	Fever (Fevers) 01/2021 - 01/2018
2	Lymphoma (Lymphomas) 01/2018 - 01/2017
2	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 01/2018 - 09/2016
2	Extramammary Paget Disease (Paget Disease, Extramammary) 01/2018 - 01/2013
2	Bullous Pemphigoid (Pemphigoid) 12/2017 - 01/2014
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2017 - 01/2015
2	Dermatofibrosarcoma 01/2017 - 05/2011
2	Fibrosis (Cirrhosis) 01/2017 - 01/2015
2	Autoimmune Diseases (Autoimmune Disease) 01/2013 - 09/2012
1	Neoplasm Metastasis (Metastasis) 09/2021
1	Erythema Nodosum 11/2020
1	Uveitis 06/2018
1	Uveomeningoencephalitic Syndrome (Vogt Koyanagi Harada Syndrome) 06/2018
1	Vitiligo 04/2018
1	Erythema 02/2018
1	Lymphomatoid Papulosis 02/2018
1	Adenocarcinoma 01/2018
1	Disease Progression 01/2018
1	Palmoplantar Keratoderma (Keratosis Palmaris et Plantaris) 09/2017
1	Keratoacanthoma 09/2017
1	Adrenocorticotropic hormone deficiency 03/2017
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 01/2017
1	Acquired ichthyosis 01/2017
1	Benign Fibrous Histiocytoma (Dermatofibroma) 01/2017
1	Ulcer 01/2017
1	Liver Diseases (Liver Disease) 09/2016
1	Inflammation (Inflammations) 01/2016
1	Rheumatoid Arthritis 05/2015
1	Drug Eruptions (Drug Eruption) 05/2015
1	Localized Scleroderma (Morphea) 01/2015

Drug/Important Bio-Agent (IBA)

13	NivolumabIBA 09/2021 - 06/2016
6	PeriostinIBA 12/2017 - 01/2015
5	IpilimumabIBA 09/2021 - 09/2016
5	trametinibIBA 03/2021 - 02/2018
5	dabrafenibIBA 03/2021 - 02/2018
5	ChemokinesIBA 01/2021 - 11/2015
3	RANK LigandIBA 01/2018 - 01/2016
3	Interleukin-17 (Interleukin 17)IBA 09/2013 - 09/2012
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 09/2021 - 09/2017
2	binimetinibIBA 03/2021 - 01/2021
2	encorafenibIBA 03/2021 - 01/2021
2	InterferonsIBA 01/2021 - 09/2014
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 03/2018
2	mogamulizumabIBA 04/2018 - 01/2018
2	AntibodiesIBA 03/2018 - 09/2017
2	Bexarotene (LGD1069)FDA Link 02/2018 - 01/2017
2	Denosumab FDA Link 01/2018 - 01/2017
2	Matrix Metalloproteinases (MMPs)IBA 01/2018 - 01/2017
2	Imiquimod (Aldara)FDA LinkGeneric 01/2018 - 01/2017
2	CytokinesIBA 01/2018 - 01/2017
2	Messenger RNA (mRNA)IBA 01/2018 - 11/2015
2	Indicators and Reagents (Reagents)IBA 01/2018 - 01/2018
2	PeplomycinIBA 01/2017 - 01/2015
2	Biological ProductsIBA 09/2016 - 05/2015
2	Therapeutic UsesIBA 06/2016 - 11/2015
2	Docetaxel (Taxotere)FDA Link 01/2013 - 01/2012
2	Risedronic Acid (Actonel)FDA LinkGeneric 01/2013 - 01/2012
2	Diphosphonates (Bisphosphonates)IBA 01/2013 - 01/2012
1	Proto-Oncogene Proteins B-rafIBA 09/2021
1	MAP Kinase Kinase Kinases (MAP Kinase Kinase Kinase)IBA 09/2021
1	HLA-DRB1*04 antigenIBA 06/2018
1	hydroxide ionIBA 04/2018
1	rhododendrolIBA 04/2018
1	Cholecalciferol (Vitamin D3)FDA Link 04/2018
1	Vitamin D FDA LinkGeneric 04/2018
1	pembrolizumabIBA 03/2018
1	Dacarbazine (DIC)FDA LinkGeneric 01/2018
1	Etoposide (VP 16)FDA LinkGeneric 01/2018
1	Vincristine (Oncovin)FDA LinkGeneric 01/2018
1	NimustineIBA 01/2018
1	Receptor Activator of Nuclear Factor-kappa B (TRANCE-R)IBA 01/2018
1	VemurafenibIBA 09/2017
1	Immune Checkpoint InhibitorsIBA 05/2017
1	Proteins (Proteins, Gene)FDA Link 01/2017
1	STAT5 Transcription FactorIBA 01/2017
1	DNA (Deoxyribonucleic Acid)IBA 01/2017
1	Interferon-alpha (Interferon Alfa)IBA 09/2016
1	Interferon-gamma (Interferon, gamma)IBA 09/2016
1	diphenylcyclopropenoneIBA 06/2016
1	squaric acidIBA 06/2016
1	HaptensIBA 06/2016
1	Interleukin-4 (Interleukin 4)IBA 02/2016
1	methyl 4-formylphenyl phosphateIBA 01/2016
1	Interferon-betaIBA 11/2015
1	Abatacept (Orencia)FDA Link 05/2015

Therapy/Procedure

19	Therapeutics 09/2021 - 01/2012
3	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 09/2021 - 05/2017
2	Radiotherapy 01/2017 - 01/2012
2	Immunotherapy 09/2016 - 06/2016
1	Phototherapy (Light Therapy) 02/2018
1	Combination Drug Therapy (Combination Chemotherapy) 01/2018
1	Drug Therapy (Chemotherapy) 01/2017
1	Indwelling Catheters (Indwelling Catheter) 01/2015